PEGylated iridium-based nano-micelle: Self-assembly, selective tumor fluorescence imaging and photodynamic therapy
Source abstract
Abstract
Abstract Poly(ethylene glycol) (PEG) as a key role can significantly affect the bio-application of imaging sensors or drugs. In this study, iridium (Ir) complexes decorated with PEG chain from 600 Da to 4000 Da were synthesized. Four amphiphilic Ir-based molecules could self-assemble to form micellar nanoparticles (IP600 NPs−IP4000 NPs). TEM results revealed that the size decreased from 76 to 34 nm with the increased PEG length, and the micellar stability increased with longer PEG length. The longer blood circulation time of IP2000 NPs and IP4000 NPs could be ascribed to the decreased serum protein adsorption in theoretically and experimentally. Fluorescence imaging study further exhibited selective tumor accumulation enhancement. Cell fluorescence imaging results revealed that cellular uptake decreased with the PEG length increase. Take multi-factors into consideration, PEG (2000 Da) is suitable for decorating a small molecule. Photodynamic therapy study also exhibited that IP2000 NPs qualified higher therapeutic effect. Biosafety study uncovered the excellent biocompatibility of IP2000 and IP4000 NPs. Our study not only proved that 2000 Da PEG is suitable for the PEGylation of small molecules to fabricate micellar nanoparticles but also supplied a self-assembled strategy for constructing a metabolizable fluorescence-imaging nano-sensors and drug delivery system.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced biosensing and bioanalysis techniques · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Water-dispersible graphene/amphiphilic pyrene derivative nanocomposite: high AuNPs loading capacity for CEA electrochemical immunosensing10.1016/j.snb.2017.02.138 ↗
2. Surface characterization and antifouling properties of nanostructured gold chips for imaging surface plasmon resonance biosensing10.1016/j.snb.2014.11.133 ↗
3. Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications10.1080/17425247.2016.1182485 ↗
4. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery10.1039/C2CS35265F ↗
5. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation10.1039/c2cs15344k ↗
6. Administration, distribution, metabolism and elimination of polymer therapeutics10.1016/j.jconrel.2011.12.021 ↗
7. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives10.1002/anie.200902672 ↗
8. Half-life extension of biopharmaceuticals using chemical methods: alternatives to PEGylation10.1002/cmdc.201600374 ↗
9. PEG - a versatile conjugating ligand for drugs and drug delivery systems10.1016/j.jconrel.2014.06.046 ↗
10. Micellar nanocarriers: pharmaceutical perspectives10.1007/s11095-006-9132-0 ↗
11. Ultrafast synthesizing bismuth mesoporous nanolitchi radiosensitizer loading high dose DOX for CT-guided enhanced chemoradiotherapy10.1021/acsami.9b13647 ↗
12. Self-assembly behavior of amphiphilic poly(ethylene glycol)-conjugated 10-hydroxycamptothecin in water and its cytotoxicity assay10.1016/j.apsusc.2018.08.082 ↗
13. pH-responsive reversible PEGylation improves performance of antineoplastic agent10.1002/adhm.201400736 ↗
14. State of the art in PEGylation: the great versatility achieved after forty years of research10.1016/j.jconrel.2011.10.037 ↗
15. Polymer–drug conjugation, recent achievements and general strategies10.1016/j.progpolymsci.2007.05.008 ↗
16. Synthesis, characterization, and in-vitro antitumor activity of the polyethylene glycol (350 and 1000) succinate derivatives of the tocopherol and tocotrienol isomers of Vitamin E10.1016/j.ijpharm.2017.01.020 ↗
17. Self-assembling doxorubicin prodrug forming nanoparticles and effectively reversing drug resistance in vitro and in vivo10.1002/adhm.201600345 ↗
18. Antitumor activity of a unique polymer that incorporates a fluorescent self-assembled metallacycle10.1021/jacs.7b09224 ↗
19. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery10.1016/j.addr.2015.09.012 ↗
20. Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells10.1039/c3nr05559k ↗
21. Effect of PEG pairing on the efficiency of cancer-targeting liposomes10.7150/thno.10732 ↗
22. The effect of surface poly(ethylene glycol) length on in vivo drug delivery behaviors of polymeric nanoparticles10.1016/j.biomaterials.2018.08.022 ↗
23. Optimization of a PEGylated glucuronide-monomethylauristatin E linker for antibody-drug conjugates10.1158/1535-7163.MCT-16-0343 ↗
24. Reducing dendrimer generation and PEG chain length increases drug release and promotes anticancer activity of PEGylated polylysine dendrimers conjugated with doxorubicin via a cathepsin-cleavable peptide linker10.1021/acs.molpharmaceut.8b00581 ↗
25. Conformation of the poly(ethylene glycol) chains in diPEGylated hemoglobin specifically probed by SANS: correlation with PEG length and in vivo efficiency10.1021/acs.langmuir.5b01121 ↗
26. Engineered paramagnetic graphene quantum dots with enhanced relaxivity for tumor imaging10.1021/acs.nanolett.8b04252 ↗
27. Effects of protein corona on active and passive targeting of cyclic RGD peptide-functionalized PEGylation nanoparticles10.1021/acs.molpharmaceut.8b00612 ↗
28. Regulating the surface poly(ethylene glycol) density of polymeric nanoparticles and evaluating its role in drug delivery in vivo10.1016/j.biomaterials.2015.07.048 ↗
29. Combinatorial chemistry and mass spectrometry in the 21st century drug discovery laboratory10.1021/cr990085q ↗
30. Applications of radiolabeled boron clusters to the diagnosis and treatment of cancer10.1021/cr980442h ↗
31. Noninvasive imaging of nanomedicines and nanotheranostics: principles, progress, and prospects10.1021/cr500314d ↗
32. New strategies for fluorescent probe design in medical diagnostic imaging10.1021/cr900263j ↗
33. Ultrasensitive near-infrared fluorescence-enhanced probe for in vivo nitroreductase imaging10.1021/jacs.5b04097 ↗
34. Dual-phosphorescent iridium(III) complexes extending oxygen sensing from hypoxia to hyperoxia10.1021/jacs.8b02492 ↗
35. Nanozyme decorated metal–organic frameworks for enhanced photodynamic therapy10.1021/acsnano.7b07746 ↗
36. Revealing the biodistribution and clearance of Ag2Se near-infrared quantum dots in mice10.1039/C7NJ02126G ↗
37. De l'effet inhibiteur exercé par l'oxygène sur la fluorescence des solutions
38. Experimental determination of oxygen and nitrogen solubility in organic solvents up to 10 MPa at temperatures between 298 K and 398 K10.1006/jcht.2001.0837 ↗
39. Origin of the strong effect of protic solvents on the emission spectra, quantum yield of fluorescence and fluorescence lifetime of 4-aminophthalimide: role of hydrogen bonds in deactivation of S1-4-aminophthalimide10.1016/j.jphotochem.2006.04.022 ↗
40. Dense and dynamic polyethylene glycol shells cloak nanoparticles from uptake by liver endothelial cells for long blood circulation10.1021/acsnano.8b04947 ↗
41. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology10.1038/nnano.2013.181 ↗
42. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts10.1073/pnas.0805135105 ↗
43. Synthesis, structure and molecular docking studies of dicopper(II) complexes bridged by N-phenolato-N'-[2-(dimethylamino)ethyl]oxamide: the influence of terminal ligands on cytotoxicity and reactivity towards DNA and protein BSA10.1039/C4NJ00092G ↗
44. The synthesis, characterization, DNA/protein interaction, molecular docking and catecholase activity of two Co(II) complexes constructed from the aroylhydrazone ligand10.1016/j.molstruc.2019.127229 ↗
45. Dual function luminescent transition metal complexes for cancer theranostics: the combination of diagnosis and therapy10.1016/j.ccr.2018.11.013 ↗
46. Kinetic and thermodynamic studies of sunitinib malate interaction with albumin using surface plasmon resonance and molecular docking methods10.1016/j.microc.2019.104089 ↗